Transcription of OCREVUS Prescribing Information - Genentech
{{id}} {{{paragraph}}}
Example: air traffic controller
OCREVUS Prescribing Information - Genentech
HIGHLIGHTS OF Prescribing INFORMATIONT hese highlights do not include all the Information needed to use OCREVUS safely and effectively. See full Prescribing Information for (ocrelizumab) injection, for intravenous useInitial Approval: 2017---------------------------RECENT MAJOR CHANGES---------------------------Dosage and Administration ( , ) 12/2020 Warnings and Precautions( , )11/2020---------------------------INDIC ATIONS AND USAGE---------------------------- OCREVUS is aCD20-directed cytolytic antibody indicated for the treatment of.
Maximum:180 mLper hour Duration:2.5hours or longer Infusion 2 (2 weeks later) 300 mg in 250 mL Subsequent ... Dose modifications in response to infusion reactions depends on the severity. ... this rate is tolerated, increase the rate as described in Table 1. This change in rate will increase the total
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: